Viral hepatitis is an inflammatory liver disease caused by infection with any of the known hepatitis viruses—A, B, C, D and E. Hepatitis B and C can be transmitted sexually and account for most of the global hepatitis burden. NIAID supports programs to improve point-of-care testing and design a vaccine for hepatitis C virus and to cure chronic hepatitis B infection.
Liver tissue specimen extracted from a viral hepatitis patient
Credit
CDC
More Hepatitis Research at NIAID
Information about hepatitis research at NIAID includes the Strategic Plan for Trans-NIH Research to Cure Hepatitis B, the latest news, and access to clinical studies.